Sarcoidosis: Clinical Trials

11 trials for Sarcoidosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 1 active not recruiting, 1 not yet recruiting. 11 Phase 1, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 111Completed 5, Terminated 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 27Completed 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1

Follow Sarcoidosis: new trials by email Literature Review of Sarcoidosis trials Research Report on Sarcoidosis

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FAPI PET Imaging - An Exploratory Study
[18F]FAPI-74 PET/CT - Thyroid Pathology, Head and Neck Cancer (H&N)
Phase 1 / Phase 2Not yet recruitingMartin Huellner7702026-08-012026-07-15
Feasibility of Semaglutide in Advanced Lung Disease
Semaglutide Pen Injector - Obesity, Interstitial Lung Disease
Phase 1 / Phase 2RecruitingUniversity of Pennsylvania82024-01-292026-04-21
Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations
XTMAB-16 or Placebo - Pulmonary Sarcoidosis
Phase 1 / Phase 2Active not recruitingXentria, Inc.322023-11-102026-10-02
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
[64]Cu Macrin - Sarcoid, Cardiovascular Diseases
Phase 1UnknownRalph Weissleder, MD1002021-09-062022-06-23
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial, Spirometry, RNA Sequencing - Sarcoidosis, Pulmonary, Sarcoidosis Lung
Phase 1CompletedOregon Health and Science University52019-05-152022-02-18
Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis
Efzofitimod 1.0 mg/kg or Placebo, Efzofitimod 3.0 mg/kg or Placebo, Efzofitimod 5.0 mg/kg or Placebo - Pulmonary Sarcoidosis
Phase 1 / Phase 2CompletedaTyr Pharma, Inc.372019-01-292023-07-18
Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study
Habitrol, Placebo to Habitrol - Sarcoidosis
Phase 1 / Phase 2CompletedOhio State University502015-10-212025-04-24
Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis
PDA001 (cenplacel-L) - Stage 2 Pulmonary Sarcoidosis, Stage 3 Pulmonary Sarcoidosis
Phase 1TerminatedCelularity Incorporated42011-09-012018-03-01
Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis
levaquin; ethambutol; rifampin and azithromycin. - Pulmonary Sarcoidosis, Lung Function
Phase 1CompletedVanderbilt University152010-07-012012-10-31
Trial of Antimycobacterial Therapy in Sarcoidosis
Antibiotic Regimen, Placebo Regimen - Sarcoidosis
Phase 1 / Phase 2CompletedVanderbilt University302010-02-012016-12-12
Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis
Autologous hematopoietic stem cell transplantation, Allogeneic stem cell transplantation - Sarcoidosis
Phase 1 / Phase 2TerminatedNorthwestern University22003-12-012018-08-31

Narrower conditions

Sarcoidosis, Pulmonary (6)  ·  Lung Diseases, Interstitial (2)  ·  Mycobacterium Infections (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Transitional Cell (1)  ·  Cardiovascular Diseases (1)  ·  Disease (1)  ·  Endometriosis (1)  ·  Granuloma (1)  ·  Head and Neck Neoplasms (1)  ·  Hypertension, Pulmonary (1)  ·  Inflammation (1)  ·  Liver Cirrhosis (1)

Broader conditions

Hemic and Lymphatic Diseases (11)  ·  Hypersensitivity (11)  ·  Hypersensitivity, Delayed (11)  ·  Immune System Diseases (11)  ·  Lymphatic Diseases (11)  ·  Lymphoproliferative Disorders (10)  ·  Lung Diseases (7)  ·  Respiratory Tract Diseases (7)  ·  Lung Diseases, Interstitial (5)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Actinomycetales Infections (2)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Cardiovascular Diseases (2)

Interventions

Azithromycin (2)  ·  Ethambutol (2)  ·  Levofloxacin (2)  ·  Rifampin (2)  ·  Adrenal Cortex Hormones (1)  ·  Clinical Laboratory Techniques (1)  ·  Clinical Trials as Topic (1)  ·  Nicotine (1)  ·  Respiratory Function Tests (1)  ·  Sequence Analysis, RNA (1)  ·  Spirometry (1)  ·  Tablets (1)  ·  semaglutide (1)  ·  tofacitinib (1)

Sponsors

Vanderbilt University (2)  ·  Celularity Incorporated (1)  ·  Martin Huellner (1)  ·  Northwestern University (1)  ·  Ohio State University (1)  ·  Oregon Health and Science University (1)  ·  Ralph Weissleder, MD (1)  ·  University of Pennsylvania (1)  ·  Xentria, Inc. (1)  ·  aTyr Pharma, Inc. (1)

Countries

United States (10)  ·  Czechia (1)  ·  Denmark (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Wonder P Drake, MD (2)  ·  Gennyne Walker (1)  ·  Jim Rosenbaum, MD (1)  ·  Michaela R Anderson, MD (1)  ·  Monica E Luchi, MD (1)  ·  Richard Burt, MD (1)

Results publications

PMID 23863960, PMID 24284293, PMID 33089005, PMID 33825964, PMID 34029565, PMID 36356657, PMID 37854715, PMID 41469153